Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
10.1111/j.1872-034X.2012.01031.x 24
GLP-1 boosts insulin secretion from pancreatic beta cells in a glucose-dependent manner (meaning it only works when blood glucose is elevated, reducing hypoglycemia risk), suppresses glucagon secretion from pancreatic alpha cells (reducing glucose production by the liver), slows gastric emptying (prolonging satiety and reducing postprandial glucose spikes), and starts GLP-1 receptors in the brain (very the hypothalamus) to reduce appetite and food intake
Jakubczyk K, Dec K, Kaduska J, Kawczuga D, Kochman J, Janda KJPmloPTL
CrossRef Constructing biomimetic microenvironments for liver regeneration Yawen Zhu, Wanqi Yang, Zhongxia Wang, Dayu Chen, Jinglin Wang, Haozhen Ren Journal of Nanobiotechnology .2025;[Epub] CrossRef Linear association between the composite dietary antioxidant index and the prevalence of sarcopenia in metabolic dysfunction-associated steatotic liver disease Jue Zhang, Huan Shi Lipids in Health and Disease .2025;[Epub] CrossRef Research trends on the quality of life in patients with metabolic dysfunction-associated fatty liver diseases: a scientific metrology study Can Huang, Meng Chen, Yanfang Sun, Lin Zhang, Wei Liu Frontiers in Nutrition .2025;[Epub] CrossRef 2025 Clinical Practice Guidelines for Diabetes: Management of Metabolic Dysfunction-Associated Steatotic Liver Disease Jaehyun Bae The Journal of Korean Diabetes .2025
Always follow the specific storage instructions on your IMP label or as directed by your trial team, as conditions may differ from licensed injectable products
DOI: 10.3390/antiox13060624 24
US$ 27.20
US$ 21.11
US$ 24.95
US$ 25.68
